Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

422.78 +3.79 (+0.90%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,064,605
Open 420.67
Bid (Size) 411.00 (1)
Ask (Size) 425.65 (1)
Prev. Close 418.99
Today's Range 417.50 - 423.32
52wk Range 320.01 - 448.40
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stock Market Moves Toward Highs; Arista, Toast, Palantir Key Earnings Movers: Weekly Review
Big earnings winners and losers continued. 
Via Investor's Business Daily
Will the Biotech Sector Shift From Lagger to Leader?
The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs. 
Via MarketBeat
Topics ETFs

Performance

YTD
+2.89%
+2.89%
1 Month
+6.34%
+6.34%
3 Month
-0.03%
-0.03%
6 Month
+13.15%
+13.15%
1 Year
+20.66%
+20.66%

More News

Read More
A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics
Via Benzinga
Smart Money Is Betting Big In VRTX Options
Via Benzinga
(VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest
Via Benzinga
Investors seeking growth at a reasonable cost should explore NASDAQ:VRTX.
Via Chartmill
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
Markets In A Minute - "A Lack Of Further Progress"
Via Talk Markets
Topics Economy Workforce
Exposures Interest Rates Layoff
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
US Stocks Eye Fourth Positive Session Despite Hawkish Fed Remarks; Disney, Palantir Tumble; Treasury Yields Fall: What's Driving Markets Tuesday?
Via Benzinga
Topics Economy
Exposures Interest Rates
VRTX Stock Earnings: Vertex Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Vertex Beats First-Quarter Expectations, But Shares Stay Flat On Reiterated Outlook
Via Investor's Business Daily
Vertex Reports First Quarter 2024 Financial Results
From Vertex Pharmaceuticals Incorporated
Via Business Wire
3 Biotech Stocks to Double Your Money in the Next 24 Months
Via InvestorPlace
3 No-Brainer Stocks to Buy in May
Via The Motley Fool
3 Biotech Stocks With the Potential to Make You an Overnight Millionaire
Via InvestorPlace
Exposures Product Safety
A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
Via Investor's Business Daily
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar
Via InvestorPlace
3 Growth Stocks You’ll Kick Yourself for Not Buying Today
Via InvestorPlace
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar
Via InvestorPlace
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
Via Benzinga
2 Top Growth Stocks to Buy Right Now and Hold Forever
Via The Motley Fool
Want $1 Million in Retirement? 3 Stocks to Buy Now And Hold for Decades.
Via The Motley Fool
$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.